Humana INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NYSE
Humana Inc. announces its 2026 Annual Meeting of Stockholders, detailing proposals for director elections, auditor ratification, executive compensation, and a new stock incentive plan, alongside a review of 2025 performance.
NYSE
Humana Inc. has scheduled its Annual Meeting of Stockholders for April 17, 2025, and is providing proxy materials to stockholders for voting on key proposals.
NYSE
Humana Inc. invites stockholders to its 2025 Annual Meeting and highlights key leadership transitions and strategic initiatives from 2024.
NYSE
Humana Inc. will hold its Annual Meeting of Stockholders on April 18, 2024, and has released proxy materials to stockholders.
NYSE
Humana's 2024 proxy statement reveals a challenging 2023 marked by unexpected medical cost increases, alongside proposals to amend the company's charter regarding officer liability and voting requirements.